WHO suspends hydroxychloroquine experiment "God medicine" for the future

,
The World Health Organization (WHO)Director-General
Tandesser
said at a press conference,
For safety reasons, WHO has suspended the treatment of hydroxychloroquine (COVID-19) trial
."The executive team has suspended the use of hydroxychloroquine in the 'Unity Trial' and the Data Safety Monitoring Board is evaluating the safety data," Mr Tandesser said. TheSolidarity Trial is a study being organized by WHO and its partners in several countries to produce reliable data and determine which treatments are most effective by comparing some untested COVID-19 treatments.WHO's decision to suspend the hydroxychloroquine experiment follows the release last week of a study on hydroxychloroquine in The Lancet. The study looked at the treatment of 96,032 patients who tested positive for SARS-CoV-2 in 671 hospitals on six continents and found that the use of the drug by COVID-19 patients could have potentially serious side effects, particularly cardiac arrhyth arrhythmics, increasing the risk of death.Hydroxychloroquine is an antimalarial drug, but statements from public figures, including U.S. President Donald Trump, have prompted governments to buy it in large quantities. Last week, Trump announced that he was taking the drug, and Brazil's health minister recommended the use of hydroxychloroquine and antimalarial chloroquine to treat mild COVID-19 cases. However, according to U.S. President Donald Trump himself, he has now suspended hydroxychloroquine.It is worth noting that, according to WHO's previous recommendations, the antimalarial drug hydroxychloroquine should only be used in clinical trials and should not be used as a treatment or prevention drug for coronary diseases.Soumya Swaminathan, WHO's chief scientist, said in a briefing on Monday that the WHO-supported solidarity trial had only looked at the role of hydroxychloroquine, not chloroquine, and that the decision to suspend the use of hydroxychloroquine for testing was "an interim measure". Currently, clinical trials of other potential new crown treatments in the Solidarity Trials are continuing. (Biological exploration)